A New Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP

被引:0
|
作者
Miura, Katsuhiro [1 ]
Konishi, Jun [2 ]
Miyake, Takaaki [3 ]
Masanori, Makita [4 ]
Hojo, Atsuko [5 ]
Masaki, Yasufumi [6 ]
Uno, Masatoshi [7 ]
Ozaki, Jun [8 ]
Yoshida, Chikamasa [9 ]
Niiya, Daigo [10 ]
Kitazume, Koichi [11 ]
Maeda, Yoshinobu [12 ]
Takizawa, Jun [13 ]
Sakai, Rika [14 ]
Nawa, Yuichiro [15 ]
Yano, Tomofumi [10 ]
Yamamoto, Kazuhiko [4 ]
Sunami, Kazutaka [2 ]
Hiramatsu, Yasushi [16 ]
Aoyama, Kazutoshi [17 ]
Tsujimura, Hideki [18 ]
Hatta, Yoshihiro [1 ]
Kanno, Masatoshi [19 ]
机构
[1] Nihon Univ, Sch Med, Dept Hematol & Rheumatol, Tokyo, Japan
[2] Natl Hosp Org Okayama Med Ctr, Dept Hematol, Okayama, Japan
[3] Shimane Univ Hosp, Dept Oncol Hematol, Izumo, Shimane, Japan
[4] Okayama City Hosp, Dept Hematol, Okayama, Japan
[5] Kasukabe Municipal Hosp, Div Hematol & Oncol, Saitama, Japan
[6] Kanazawa Med Univ, Dept Hematol & Immunol, Uchinada, Ishikawa 92002, Japan
[7] Kaneda Hosp, Div Internal Med, Okayama, Japan
[8] Toyama Prefectural Cent Hosp, Dept Hematol, Toyama, Japan
[9] Natl Hosp Org Minami Okayama Med Ctr, Dept Hematol, Okayama, Japan
[10] Okayama Rosai Hosp, Dept Hematol, Okayama, Japan
[11] Showa Gen Hosp, Dept Hematol, Tokyo, Japan
[12] Okayama Univ, Dept Hematol & Oncol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan
[13] Niigata Univ, Fac Med, Dept Hematol Endocrinol & Metab, Niigata, Japan
[14] Kanagawa Canc Ctr, Dept Med Oncol, Yokohama, Kanagawa 2410815, Japan
[15] Ehime Prefectural Cent Hosp, Div Hematol, Matsuyama, Ehime, Japan
[16] Himeji Red Cross Hosp, Dept Haematol & Oncol, Himeji, Hyogo, Japan
[17] Chugoku Cent Hosp, Dept Hematol, Hiroshima, Japan
[18] Chiba Canc Ctr, Dept Hematol Oncol, Chiba 2608717, Japan
[19] Nara Med Univ Hosp, Ctr Oncol, Kashihara, Nara, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Use of the Lymphgen Tool in a Cohort of Patients with Diffuse Large B-cell Lymphoma Treated with R-CHOP
    Jackson, Ryan
    Perry, Anamarija
    Herrera, Alex
    Bedell, Victoria
    Murata-Collins, Joyce
    Rahimi, Nina
    Pillai, Raju
    Chan, Wing
    Weisenburger, Dennis
    Song, Joo
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 845 - 846
  • [32] Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP
    Wang, Yu
    Li, Ya-Jun
    Jiang, Wen-Qi
    Rao, Hui-Lan
    Huang, Jia-Jia
    Xia, Yi
    Bi, Xiwen
    Sun, Peng
    Huang, Hui-Qiang
    Lin, Tong-Yu
    Guan, Zhong-Zhen
    Li, Zhi-Ming
    ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1865 - 1873
  • [33] Influence of NK cell count on the survival of patients with diffuse large B-cell lymphoma treated with R-CHOP
    Kim, Joong-Keun
    Chung, Joo-Seop
    Shin, Ho-Jin
    Song, Moo-Kon
    Yi, Ji-Won
    Shin, Dong-Hun
    Lee, Dae-Sung
    Baek, Sung-Min
    BLOOD RESEARCH, 2014, 49 (03) : 162 - 169
  • [34] Prognostic significance of PRAME expression based on immunohistochemistry for diffuse large B-cell lymphoma patients treated with R-CHOP therapy
    Kenjiro Mitsuhashi
    Akihiro Masuda
    Yan-Hua Wang
    Masayuki Shiseki
    Toshiko Motoji
    International Journal of Hematology, 2014, 100 : 88 - 95
  • [35] The Immunohistochemical Profile and Other Prognostic Factors In Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Castillo, Jorge J.
    Beltran, Brady
    Chung, Joo-Seop
    Ilic, Ivana
    Leppa, Sirpa
    Seki, Ritsuko
    Uccella, Silvia
    Xia, Zu-Guang
    Butera, James N.
    BLOOD, 2010, 116 (21) : 1679 - 1679
  • [36] THE PROGNOSTIC SIGNIFICANCE OF THE NUMBER OF EXTRANODAL INVOLVEMENT SITES IN THE PATIENTS WITH DISSEMINATED DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH R-CHOP
    Yoo, C.
    Sohn, B. S.
    Kim, J. E.
    Yoon, D. H.
    Kim, S.
    Lee, D. H.
    Kim, S. W.
    Suh, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 400 - 401
  • [37] Prognostic significance of PRAME expression based on immunohistochemistry for diffuse large B-cell lymphoma patients treated with R-CHOP therapy
    Mitsuhashi, Kenjiro
    Masuda, Akihiro
    Wang, Yan-Hua
    Shiseki, Masayuki
    Motoji, Toshiko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (01) : 88 - 95
  • [38] Prognostic Significance Of Systemic Inflammatory Factors In Patients With Diffuse Large B Cell Lymphoma Treated By R-CHOP
    Yoh, Kyung Ah
    Lee, Ho Sup
    Park, Lee Chun
    Lee, Eun Mi
    Shin, Seong Hoon
    Ye, Byeong Jin
    Moon, Joon Ho
    Jo, Jae-Cheol
    Lee, Won Sik
    Shin, Ho-Jin
    Oh, Sun Young
    Kim, Yang Soo
    BLOOD, 2013, 122 (21)
  • [39] Primary Cutaneous Diffuse Large B-cell Lymphoma Successfully Treated With R-CHOP Chemotherapy
    Alghamdi, Wafa M.
    Aljehani, Fawaz H.
    Alharthi, Abdullah M.
    Bakhsh, Reda I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [40] Managing early failures with R-CHOP in patients with diffuse large B-cell lymphoma
    Camus, Vincent
    Tilly, Herve
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (12) : 1047 - 1055